financetom
Business
financetom
/
Business
/
Novo Nordisk to offer Ozempic for $499 per month
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk to offer Ozempic for $499 per month
Aug 18, 2025 6:23 AM

Aug 18 (Reuters) - Novo Nordisk said on

Monday that it was launching a new offer for self-paying type 2

diabetes patients to access authentic Ozempic for $499 per

month.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Advanced Micro Devices Unusual Options Activity
Advanced Micro Devices Unusual Options Activity
Sep 11, 2024
Deep-pocketed investors have adopted a bearish approach towards Advanced Micro Devices ( AMD ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMD usually suggests something big is about to happen. We gleaned this...
Diamondback Energy Completes Merger With Endeavor Energy Resources
Diamondback Energy Completes Merger With Endeavor Energy Resources
Sep 11, 2024
09:48 AM EDT, 09/10/2024 (MT Newswires) -- Diamondback Energy ( FANG ) said Tuesday it has completed its merger with Endeavor Energy Resources. Shares of Diamondback were down 1.4% in recent Tuesday trading. Price: 176.66, Change: -2.55, Percent Change: -1.42 ...
Arrowhead Pharmaceuticals' Plozasiran Receives FDA Breakthrough Therapy Designation
Arrowhead Pharmaceuticals' Plozasiran Receives FDA Breakthrough Therapy Designation
Sep 11, 2024
08:38 AM EDT, 09/10/2024 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Tuesday that the US Food and Drug Administration has granted breakthrough therapy designation to plozasiran as an adjunct treatment for adults with familial chylomicronemia syndrome. The designation is intended to expedite the development and review of drugs that treat a serious condition and that may demonstrate substantial...
Keurig Dr Pepper to Pay $1.5 Million Fine to Settle SEC Charges Over Recyclability Claims of K-Cup Pods
Keurig Dr Pepper to Pay $1.5 Million Fine to Settle SEC Charges Over Recyclability Claims of K-Cup Pods
Sep 11, 2024
09:48 AM EDT, 09/10/2024 (MT Newswires) -- The US Securities and Exchange Commission said Tuesday that Keurig Dr Pepper ( KDP ) will pay a $1.5 million fine to settle charges due to inaccurate statements related to the recyclability of its K-Cup pods. The regulator said that in annual reports for fiscal 2019 and 2020 Keurig said that its testing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved